4//SEC Filing
EYEGATE PHARMACEUTICALS INC 4
Accession 0001144204-17-033632
$KPRXCIK 0001372514operating
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:24 PM ET
Size
5.6 KB
Accession
0001144204-17-033632
Insider Transaction Report
Form 4
Wirostko Barbara
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2017-06-21+35,000→ 35,000 totalExercise: $1.35Exp: 2027-06-21→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on June 21, 2018, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeoperating
Related Parties
1- filerCIK 0001372514
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:24 PM ET
- Size
- 5.6 KB